[1]王于静,陈晗婷,王维广,等.中医古籍文本理论内容的标引方法及思考[J].西部中医药,2025,38(02):44-47.[doi:10.12174/j.issn.2096-9600.2025.02.12]
 WANG Yujing,CHEN Hanting,WANG Weiguang,et al.Methods and Reflections on the Citation of Theoretical Contents of Ancient Chinese Medicine Texts[J].Western Journal of Traditional Chinese Medicine,2025,38(02):44-47.[doi:10.12174/j.issn.2096-9600.2025.02.12]
点击复制

中医古籍文本理论内容的标引方法及思考()
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年02期
页码:
44-47
栏目:
医史文献
出版日期:
2025-02-15

文章信息/Info

Title:
Methods and Reflections on the Citation of Theoretical Contents of Ancient Chinese Medicine Texts
作者:
王于静, 陈晗婷, 王维广, 刘晓峰, 翟双庆
北京中医药大学,北京 100029
Author(s):
WANG Yujing, CHEN Hanting, WANG Weiguang, LIU Xiaofeng, ZHAI Shuangqing
Beijing University of Chinese Medicine, Beijing 100029, China
关键词:
中医理论古籍文本知识标引知识图谱
Keywords:
TCM theoryancient textscitationsknowledge map
分类号:
R2-03
DOI:
10.12174/j.issn.2096-9600.2025.02.12
文献标志码:
A
摘要:
对同一段中医古籍文本理论内容进行标引,并分析不同标引方式的优点及不足,指出“病脉证并治平台”自上而下的标引方法与“经典知识平台”自下而上的标引方法在知识框架、形成知识图谱、标引自由度、标引模板等方面各有优势,应根据实际需求选择相应标引方法。并得出如有明确研究目标或需要构建完整知识框架时,应选择“病脉证并治平台”标引方法;如需求为建立相应知识图谱或需要进一步进行知识挖掘时,则选择“经典知识平台”标引方法更为恰当。
Abstract:
By indexing theoretical contents in the same ancient Chinese medicine texts, the advantages and disadvantages of different citation methods were analyzed in the paper, the top-down citation method for "treatment platform of disease, pulse and syndrome" and bottom-up citation approach for "classic knowledge platform" have their own advantages in knowledge frameworks, forming knowledge graphs, degrees of freedom for citation and citation templates, the corresponding citation method should be chosen according to the practical need. Citation method for "treatment platform of disease, pulse and syndrome" could be selected if there are clear research objectives or the complete knowledge frameworks need to be constructed; citation approach for "classic knowledge platform" are more appropriate if the need is to establish the corresponding knowledge graphs or further knowledge mining is needed.

相似文献/References:

[1]屈少雄.《周易》对中医理论发展的影响[J].西部中医药,2018,31(01):38.
 QU Shaoxiong.The Influence of the Book of Changes on the Development of TCM Theory[J].Western Journal of Traditional Chinese Medicine,2018,31(02):38.
[2]汪六林,巴元明△,李 刚,等.中医药防治新型冠状病毒肺炎研究*[J].西部中医药,2020,33(S1):44.
 WANG Liulin,BA Yuanming,LI Gan,et al.The Study on TCM in the Prevention and Treatment of COVID - 19[J].Western Journal of Traditional Chinese Medicine,2020,33(02):44.
[3]马铭泽,孟静岩.试论唐荣川《血证论》痰瘀相关思想[J].西部中医药,2022,35(03):61.[doi:10.12174/j.issn.2096-9600.2022.03.14]
 MA Mingze,MENG Jingyan.On the Related Thoughts of Phlegm and Blood Stasis in Tang Rongchuan’s Blood Syndrome Theory[J].Western Journal of Traditional Chinese Medicine,2022,35(02):61.[doi:10.12174/j.issn.2096-9600.2022.03.14]
[4]孙榕,赵泉霖.芪归药对防治糖尿病肾病的研究进展[J].西部中医药,2023,36(09):141.[doi:10.12174/j.issn.2096-9600.2023.09.31]
 SUN Rong,ZHAO Quanlin.Research Progress of Qigui Medicinal Pair in the Prevention and Treatment of Diabetic Kidney Disease[J].Western Journal of Traditional Chinese Medicine,2023,36(02):141.[doi:10.12174/j.issn.2096-9600.2023.09.31]
[5]郑倩倩,陈璐瑶,汪涛.中药有效成分防治前列腺癌的研究进展[J].西部中医药,2024,37(07):83.[doi:10.12174/j.issn.2096-9600.2024.07.20]
 ZHENG Qianqian,CHEN Luyao,WANG Tao.Research Progress on Active Ingredients in Traditional Chinese Medicine for Prostate Cancer[J].Western Journal of Traditional Chinese Medicine,2024,37(02):83.[doi:10.12174/j.issn.2096-9600.2024.07.20]

备注/Memo

备注/Memo:
王于静(1999—),女,在读硕士研究生。研究方向:肾脏疾病的中医诊治。国家中医药管理局高水平中医药重点学科建设项目(zyyzdxk-2023252);科技部科技基础资源调查专项(2022FY102000,2022FY102002);中央高校基本科研业务费专项资金资助项目(2022-JYB-JBZR-011);北京市社科基金规划项目(23LSC019)。
更新日期/Last Update: 2025-02-15